VANTRELA ER Trademark

Trademark Overview

On Friday, January 13, 2017, a trademark application was filed for VANTRELA ER with the United States Patent and Trademark Office. The USPTO has given the VANTRELA ER trademark a serial number of 87300728. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2019. This trademark is owned by Cephalon, Inc.. The VANTRELA ER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
vantrela er

General Information

Serial Number87300728
Word MarkVANTRELA ER
Filing DateFriday, January 13, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 1, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements

Disclaimer with Predetermined Text"ER"
Goods and ServicesPharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCephalon, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355
Party NameCephalon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355

Trademark Events

Event DateEvent Description
Monday, July 1, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 1, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2018EXTENSION 3 GRANTED
Tuesday, November 27, 2018EXTENSION 3 FILED
Tuesday, November 27, 2018TEAS EXTENSION RECEIVED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018EXTENSION 2 GRANTED
Thursday, May 24, 2018EXTENSION 2 FILED
Thursday, May 24, 2018TEAS EXTENSION RECEIVED
Thursday, May 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2017EXTENSION 1 GRANTED
Monday, November 27, 2017EXTENSION 1 FILED
Monday, November 27, 2017TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 13, 2017EXAMINER'S AMENDMENT ENTERED
Monday, February 13, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 13, 2017EXAMINERS AMENDMENT E-MAILED
Monday, February 13, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 25, 2017ASSIGNED TO EXAMINER
Saturday, January 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

vantrela pain treatment preparations pharmaceutical